|
tert-butyl (2S)-2-(2-methoxy-2-oxoethyl)piperazine-1-carboxylate
|
T627972-1g
|
≥97% |
1262892-01-2 |
1g
|
¥ 2903.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl (2S)-2-(2-methoxy-2-oxoethyl)piperazine-1-carboxylate
|
T627972-100mg
|
≥97% |
1262892-01-2 |
100mg
|
¥ 723.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-tert-butyl 3-ethyl (3R,4S)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride
|
T627970-5g
|
≥97% |
1262849-90-0 |
5g
|
¥ 19305.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-tert-butyl 3-ethyl (3R,4S)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride
|
T627970-500mg
|
≥97% |
1262849-90-0 |
500mg
|
¥ 2572.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-tert-butyl 3-ethyl (3R,4S)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride
|
T627970-250mg
|
≥97% |
1262849-90-0 |
250mg
|
¥ 1542.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-tert-butyl 3-ethyl (3R,4S)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride
|
T627970-1g
|
≥97% |
1262849-90-0 |
1g
|
¥ 3861.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-tert-butyl 3-ethyl (3R,4S)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride
|
T627970-100mg
|
≥97% |
1262849-90-0 |
100mg
|
¥ 968.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627967-500mg
|
≥97% |
1262410-57-0 |
500mg
|
¥ 5119.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627967-250mg
|
≥97% |
1262410-57-0 |
250mg
|
¥ 3073.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627967-1g
|
≥97% |
1262410-57-0 |
1g
|
¥ 9218.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627967-100mg
|
≥97% |
1262410-57-0 |
100mg
|
¥ 1918.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl 3-(bromomethyl)-3-fluoropiperidine-1-carboxylate
|
T627965-5g
|
≥97% |
1262409-57-3 |
5g
|
¥ 18150.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl 3-(bromomethyl)-3-fluoropiperidine-1-carboxylate
|
T627965-500mg
|
≥97% |
1262409-57-3 |
500mg
|
¥ 2420.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl 3-(bromomethyl)-3-fluoropiperidine-1-carboxylate
|
T627965-250mg
|
≥97% |
1262409-57-3 |
250mg
|
¥ 1450.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl 3-(bromomethyl)-3-fluoropiperidine-1-carboxylate
|
T627965-1g
|
≥97% |
1262409-57-3 |
1g
|
¥ 3630.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl 3-(bromomethyl)-3-fluoropiperidine-1-carboxylate
|
T627965-100mg
|
≥97% |
1262409-57-3 |
100mg
|
¥ 908.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl N-[(4-aminotetrahydrothiopyran-4-yl)methyl]carbamate
|
T627963-5g
|
≥97% |
1262409-21-1 |
5g
|
¥ 10560.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl N-[(4-aminotetrahydrothiopyran-4-yl)methyl]carbamate
|
T627963-1g
|
≥97% |
1262409-21-1 |
1g
|
¥ 2770.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl N-[(4-aminotetrahydrothiopyran-4-yl)methyl]carbamate
|
T627963-10g
|
≥97% |
1262409-21-1 |
10g
|
¥ 21120.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627962-500mg
|
≥97% |
1262408-18-3 |
500mg
|
¥ 4268.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627962-250mg
|
≥97% |
1262408-18-3 |
250mg
|
¥ 2558.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627962-1g
|
≥97% |
1262408-18-3 |
1g
|
¥ 7682.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-tert-butoxycarbonyl-1,4-oxazepane-3-carboxylic acid
|
T627962-100mg
|
≥97% |
1262408-18-3 |
100mg
|
¥ 1601.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
tert-butyl 7-hydroxy-5-azaspiro[2.4]heptane-5-carboxylate
|
T627961-5g
|
≥97% |
1262407-85-1 |
5g
|
¥ 21912.9
|
期货,请咨询 |
|
0 |
阿拉丁 |